細菌性膣炎の世界市場レポート 2025年

細菌性膣炎市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.4％で47億5,000万米ドルに成長します。この予測期間における成長は、細菌性膣炎の普及率の増加、機能性食品に対する需要の高まり、STIの発生率の増加、女性の健康状態の蔓延の増加、更年期に対する意識の高まりに起因しています。この期間に予想される主な動向には、診断における人工知能（AI）の統合、プロバイオティクスの採用、在宅STI検査の進歩、女性用健康機器における持続可能な素材の使用などがあります。

性感染症（STI）の罹患率の上昇が細菌性膣炎市場の成長を促進すると予想されます。STIは主に性的接触によって感染する感染症で、細菌、ウイルス、寄生虫によって引き起こされます。無防備な性行為、複数のパートナー、認識不足、抗生物質耐性など、いくつかの要因がSTIの蔓延を増加させています。細菌性膣炎は、膣内の細菌バランスを崩し、HIVやクラミジアなどの感染症が定着しやすくすることで、STIに対する脆弱性を高めます。例えば、2024年3月、スウェーデンに本拠を置く政府機関である欧州疾病予防管理センター（ECDC）は、2022年のSTI患者数が前年に比べて大幅に増加し、淋病が48％、梅毒が34％、クラミジアが16％増加したと報告しました。その結果、STI罹患率の増加が細菌性膣炎市場の拡大に拍車をかけています。

細菌性膣炎市場の主要企業は、診断と治療を加速するために、多重化ポリメラーゼ連鎖反応（PCR）検査などの革新的ソリューションを開発しています。多重PCR検査は、1回の実験で複数の標的DNAまたはRNA配列の同時増幅と検出を可能にします。例えば、2022年11月、米国のバイオテクノロジー研究会社であるセファイド社は、Xpert Xpress Multiplex Vaginal Panel（MVP）を発売しました。この検査は60分以内に迅速な結果をもたらし、1つのサンプルから3つの膣感染症細菌性膣炎（BV）、外陰膣カンジダ症（VVC）、トリコモナス症（TV）を検出します。臨床医が採取した綿棒と自分で採取した綿棒の両方に対応するように設計されたこの検査は、診断精度と治療成績を向上させる自動リアルタイムPCR技術を利用しています。汎用性が高いため、さまざまな臨床現場で使用でき、膣感染症の効率的で正確な検出を確実にします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界細菌性膣炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の細菌性膣炎市場：成長率分析
• 世界の細菌性膣炎市場の実績：規模と成長, 2019-2024
• 世界の細菌性膣炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界細菌性膣炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の細菌性膣炎市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポイントオブケア検査
• 臨床検査
• その他のタイプ
• 世界の細菌性膣炎市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 15歳未満
• 15～45歳
• 44歳以上
• 妊婦
• その他の製品
• 世界の細菌性膣炎市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• その他の用途
• 世界の細菌性膣炎市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の細菌性膣炎市場、タイプ別POC検査のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 迅速診断検査
• 顕微鏡検査に基づく検査
• 免疫測定
• 世界の細菌性膣炎市場、臨床検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• グラム染色
• ポリメラーゼ連鎖反応（PCR）
• DNAプローブ検査
• 文化に基づくテスト
• 世界の細菌性膣炎市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 家庭用検査キット
• 酵素免疫測定（ELISA）

第7章 地域別・国別分析

• 世界の細菌性膣炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の細菌性膣炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細菌性膣炎市場：競合情勢
• 細菌性膣炎市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Thermo Fisher Scientific
• Becton Dickinson
• Viatris Inc.
• Otsuka Pharmaceutical
• LabCorp
• Quest Diagnostics
• Organon & Co.
• UT Southwestern Medical Center
• Hologic Inc.
• bioMerieux SA
• Shionogi & Company Limited
• Melinta Therapeutics Inc.
• Evofem Biosciences
• Gedea Biotech
• Fleurstat

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 細菌性膣炎市場2029：新たな機会を提供する国
• 細菌性膣炎市場2029：新たな機会を提供するセグメント
• 細菌性膣炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bacterial vaginosis (BV) is a prevalent vaginal infection resulting from an imbalance in naturally occurring bacteria. This imbalance leads to a reduction in lactobacilli and an overgrowth of anaerobic bacteria. Common symptoms include a fishy odor, thin grayish-white discharge, and vaginal discomfort, though some cases may be asymptomatic.

The primary categories of bacterial vaginosis include point-of-care testing, laboratory testing, and others. Point-of-care testing (POCT) involves medical diagnostic tests conducted at or near the patient's location, delivering rapid results for immediate clinical decision-making. Various product categories include those designed for individuals under 15 years, those aged 15-45 years, and others. Applications consist of antibiotics and alternative treatments, utilized by different end users such as hospitals, home care settings, specialty clinics, and others.

The bacterial vaginosis market research report is one of a series of new reports from The Business Research Company that provides bacterial vaginosis market statistics, including the bacterial vaginosis industry's global market size, regional shares, competitors with a bacterial vaginosis market share, detailed bacterial vaginosis market segments, market trends and opportunities, and any further data you may need to thrive in the bacterial vaginosis industry. This bacterial vaginosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bacterial vaginosis market size has grown strongly in recent years. It will grow from $3.03 billion in 2024 to $3.32 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to the increased adoption of point-of-care diagnostics, the expansion of e-commerce, a rise in risky sexual behaviors, the growth of STI vaccination, and improved healthcare access.

The bacterial vaginosis market size is expected to see strong growth in the next few years. It will grow to $4.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to the increasing prevalence of bacterial vaginosis, rising demand for functional foods, a growing incidence of STIs, the increasing prevalence of women's health conditions, and greater awareness of menopause. Key trends expected during this period include the integration of artificial intelligence (AI) in diagnostics, the adoption of probiotics, advancements in home-based STI testing, and the use of sustainable materials in women's health devices.

The rising incidence of sexually transmitted infections (STIs) is expected to drive the growth of the bacterial vaginosis market. STIs are infections primarily transmitted through sexual contact and can be caused by bacteria, viruses, or parasites. Several factors contribute to the increasing prevalence of STIs, including unprotected sex, multiple partners, lack of awareness, and antibiotic resistance. Bacterial vaginosis increases vulnerability to STIs by disrupting the vaginal bacterial balance, making it easier for infections such as HIV and chlamydia to take hold. For example, in March 2024, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported a significant rise in STI cases in 2022 compared to the previous year, with gonorrhea increasing by 48%, syphilis by 34%, and chlamydia by 16%. As a result, the growing incidence of STIs is fueling the expansion of the bacterial vaginosis market.

Leading companies in the bacterial vaginosis market are developing innovative solutions such as multiplexed polymerase chain reaction (PCR) tests to accelerate diagnosis and treatment. A multiplexed PCR test enables the simultaneous amplification and detection of multiple target DNA or RNA sequences within a single experiment. For instance, in November 2022, Cepheid, a US-based biotechnology research company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP). This test delivers rapid results in under 60 minutes and detects three vaginal infections bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV) from a single sample. Designed for both clinician-collected and self-collected swabs, the test utilizes automated real-time PCR technology to improve diagnostic accuracy and treatment outcomes. Its versatility allows for use in various clinical settings, ensuring efficient and precise detection of vaginal infections.

In July 2024, Evofem Biosciences, a US-based biopharmaceutical company, acquired the US commercial women's health specialty business from Lupin Limited for $84 million. This acquisition is intended to expand Evofem Biosciences' portfolio in women's health by adding an FDA-approved treatment for bacterial vaginosis and trichomoniasis. Lupin Limited, an India-based pharmaceutical company, specializes in the development and distribution of a wide range of healthcare products, including women's health specialty treatments.

Major players in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMerieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, and Medical Diagnostic Laboratories.

North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in bacterial vaginosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bacterial vaginosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bacterial vaginosis market includes revenues earned by entities by providing services such as wet mount microscopy, pH testing, and dietary recommendations. The market value includes the value of related goods sold by the service provider or included within the service offering. The bacterial vaginosis (BV) market consists of sales of oral and topical antibiotics, probiotics, pH balancers, gels, and creams. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bacterial Vaginosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bacterial vaginosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bacterial vaginosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bacterial vaginosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Point-Of-Care Testing; Laboratory Testing; Other Types
• 2) By Product: Below 15 Years; Between 15-45; Other Products
• 3) By Application: Antibiotics; Other Applications
• 4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Point-Of-Care Testing: Rapid Diagnostic Tests; Microscopy-based Tests; Immunoassays
• 2) By Laboratory Testing: Gram Staining; Polymerase Chain Reaction (PCR); DNA Probe Tests; Culture-based Testing
• 3) By Other Types: Home Testing Kits; Enzyme-linked Immunosorbent Assay (ELISA)
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Merck KGaA; Bayer AG; Sanofi SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bacterial Vaginosis Market Characteristics

3. Bacterial Vaginosis Market Trends And Strategies

4. Bacterial Vaginosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bacterial Vaginosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bacterial Vaginosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bacterial Vaginosis Market Growth Rate Analysis
• 5.4. Global Bacterial Vaginosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bacterial Vaginosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bacterial Vaginosis Total Addressable Market (TAM)

6. Bacterial Vaginosis Market Segmentation

• 6.1. Global Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Point-Of-Care Testing
• Laboratory Testing
• Other Types
• 6.2. Global Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Below 15 Years
• Between 15-45
• Above 44 Years
• Pregnant Women
• Other Products
• 6.3. Global Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Other Applications
• 6.4. Global Bacterial Vaginosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.5. Global Bacterial Vaginosis Market, Sub-Segmentation Of Point-Of-Care Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Diagnostic Tests
• Microscopy-based Tests
• Immunoassays
• 6.6. Global Bacterial Vaginosis Market, Sub-Segmentation Of Laboratory Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gram Staining
• Polymerase Chain Reaction (PCR)
• DNA Probe Tests
• Culture-based Testing
• 6.7. Global Bacterial Vaginosis Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Home Testing Kits
• Enzyme-linked Immunosorbent Assay (ELISA)

7. Bacterial Vaginosis Market Regional And Country Analysis

• 7.1. Global Bacterial Vaginosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bacterial Vaginosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bacterial Vaginosis Market

• 8.1. Asia-Pacific Bacterial Vaginosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bacterial Vaginosis Market

• 9.1. China Bacterial Vaginosis Market Overview
• 9.2. China Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bacterial Vaginosis Market

• 10.1. India Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bacterial Vaginosis Market

• 11.1. Japan Bacterial Vaginosis Market Overview
• 11.2. Japan Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bacterial Vaginosis Market

• 12.1. Australia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bacterial Vaginosis Market

• 13.1. Indonesia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bacterial Vaginosis Market

• 14.1. South Korea Bacterial Vaginosis Market Overview
• 14.2. South Korea Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bacterial Vaginosis Market

• 15.1. Western Europe Bacterial Vaginosis Market Overview
• 15.2. Western Europe Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bacterial Vaginosis Market

• 16.1. UK Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bacterial Vaginosis Market

• 17.1. Germany Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bacterial Vaginosis Market

• 18.1. France Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bacterial Vaginosis Market

• 19.1. Italy Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bacterial Vaginosis Market

• 20.1. Spain Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bacterial Vaginosis Market

• 21.1. Eastern Europe Bacterial Vaginosis Market Overview
• 21.2. Eastern Europe Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bacterial Vaginosis Market

• 22.1. Russia Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bacterial Vaginosis Market

• 23.1. North America Bacterial Vaginosis Market Overview
• 23.2. North America Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bacterial Vaginosis Market

• 24.1. USA Bacterial Vaginosis Market Overview
• 24.2. USA Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bacterial Vaginosis Market

• 25.1. Canada Bacterial Vaginosis Market Overview
• 25.2. Canada Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bacterial Vaginosis Market

• 26.1. South America Bacterial Vaginosis Market Overview
• 26.2. South America Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bacterial Vaginosis Market

• 27.1. Brazil Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bacterial Vaginosis Market

• 28.1. Middle East Bacterial Vaginosis Market Overview
• 28.2. Middle East Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bacterial Vaginosis Market

• 29.1. Africa Bacterial Vaginosis Market Overview
• 29.2. Africa Bacterial Vaginosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bacterial Vaginosis Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bacterial Vaginosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bacterial Vaginosis Market Competitive Landscape And Company Profiles

• 30.1. Bacterial Vaginosis Market Competitive Landscape
• 30.2. Bacterial Vaginosis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Bacterial Vaginosis Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific
• 31.2. Becton Dickinson
• 31.3. Viatris Inc.
• 31.4. Otsuka Pharmaceutical
• 31.5. LabCorp
• 31.6. Quest Diagnostics
• 31.7. Organon & Co.
• 31.8. UT Southwestern Medical Center
• 31.9. Hologic Inc.
• 31.10. bioMerieux SA
• 31.11. Shionogi & Company Limited
• 31.12. Melinta Therapeutics Inc.
• 31.13. Evofem Biosciences
• 31.14. Gedea Biotech
• 31.15. Fleurstat

32. Global Bacterial Vaginosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bacterial Vaginosis Market

34. Recent Developments In The Bacterial Vaginosis Market

35. Bacterial Vaginosis Market High Potential Countries, Segments and Strategies

• 35.1 Bacterial Vaginosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bacterial Vaginosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bacterial Vaginosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer